Thompson MD - Search Results

1

Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models.

Al-Homoud S, Purkayastha S, Aziz O, Smith JJ, Thompson MD, Darzi AW, Stamatakis JD, Tekkis PP. Al-Homoud S, et al. Among authors: thompson md. Surg Oncol. 2004 Aug-Nov;13(2-3):83-92. doi: 10.1016/j.suronc.2004.08.006. Surg Oncol. 2004. PMID: 15572090

2

The United Kingdom National Bowel Cancer Project -- epidemiology and surgical risk in the elderly.

Tan E, Tilney H, Thompson M, Smith J, Tekkis PP; Association of Coloproctology of Great Britain and Ireland. Tan E, et al. Eur J Cancer. 2007 Oct;43(15):2285-94. doi: 10.1016/j.ejca.2007.06.009. Epub 2007 Aug 2. Eur J Cancer. 2007. PMID: 17681782

3

Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.

Malik H, Khan AZ, Berry DP, Cameron IC, Pope I, Sherlock D, Helmy S, Byrne B, Thompson M, Pulfer A, Davidson B. Malik H, et al. Eur J Surg Oncol. 2015 Apr;41(4):499-505. doi: 10.1016/j.ejso.2015.01.032. Epub 2015 Feb 7. Eur J Surg Oncol. 2015. PMID: 25703078 Free article.

4

Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system.

Rabeneck L, Davila JA, Thompson M, El-Serag HB. Rabeneck L, et al. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1115-24. doi: 10.1111/j.1365-2036.2004.02215.x. Aliment Pharmacol Ther. 2004. PMID: 15569114 Free article.

5

Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System.

Rabeneck L, Davila JA, Thompson M, El-Serag HB. Rabeneck L, et al. Am J Gastroenterol. 2004 Apr;99(4):668-75. doi: 10.1111/j.1572-0241.2004.04135.x. Am J Gastroenterol. 2004. PMID: 15089900

6

G protein-coupled receptor (GPCR) pharmacogenomics.

Thompson MD, Reiner-Link D, Berghella A, Rana BK, Rovati GE, Capra V, Gorvin CM, Hauser AS. Thompson MD, et al. Crit Rev Clin Lab Sci. 2024 Aug 9:1-44. doi: 10.1080/10408363.2024.2358304. Online ahead of print. Crit Rev Clin Lab Sci. 2024. PMID: 39119983 Review.

7

Innovations in Phenotyping and Diagnostics Create Opportunities for Improved Treatment and Genetic Counseling for Rare Diseases.

Thompson MD. Thompson MD. Genes (Basel). 2024 May 31;15(6):715. doi: 10.3390/genes15060715. Genes (Basel). 2024. PMID: 38927651 Free PMC article.

8

FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer.

Fusco MJ, Casak SJ, Mushti SL, Cheng J, Christmas BJ, Thompson MD, Fu W, Wang H, Yoon M, Yang Y, Moore JN, Bi Y, Nan Y, Long CE, Auth D, Rahman NA, Tang S, Pazdur R, Fashoyin-Aje LA, Kluetz PG, Lemery SJ. Fusco MJ, et al. Among authors: thompson md. Clin Cancer Res. 2024 Aug 1;30(15):3100-3104. doi: 10.1158/1078-0432.CCR-24-0281. Clin Cancer Res. 2024. PMID: 38809262 Clinical Trial.

9

Rare Genetic Developmental Disabilities: Mabry Syndrome (MIM 239300) Index Cases and Glycophosphatidylinositol (GPI) Disorders.

Thompson MD, Knaus A. Thompson MD, et al. Genes (Basel). 2024 May 14;15(5):619. doi: 10.3390/genes15050619. Genes (Basel). 2024. PMID: 38790248 Free PMC article. Review.

10

Pharmacokinetic models for first-in-human dose selection of immune-activating products in oncology.

Saber H, Thompson MD, Leighton JK. Saber H, et al. Among authors: thompson md. Regul Toxicol Pharmacol. 2024 May;149:105616. doi: 10.1016/j.yrtph.2024.105616. Epub 2024 Mar 30. Regul Toxicol Pharmacol. 2024. PMID: 38561147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters